Treatment of Symptomatic Convergence Insufficiency in Children Enrolled in the Convergence Insufficiency Treatment Trial-Attention & Reading Trial: A Randomized Clinical Trial

CITT-ART Investigator Group, CITT-ART Investigator Group

Abstract

Significance: These data confirm the effectiveness of office-based vergence/accommodative therapy for improving convergence in children with symptomatic convergence insufficiency. They also highlight the importance of using a primary outcome measure that is as objective as possible rather than relying solely on self-reported symptoms for studies of binocular vision in children.

Purpose: The purpose of this study was to report changes in clinical signs and symptoms of convergence insufficiency (secondary outcome measures) from a multicenter clinical trial (Convergence Insufficiency Treatment Trial-Attention & Reading Trial [CITT-ART]) evaluating the effectiveness of vergence/accommodative therapy for improving reading and attention in children with symptomatic convergence insufficiency.

Methods: Three hundred eleven children aged 9 to 14 years with symptomatic convergence insufficiency were randomly assigned to 16 weeks of office-based vergence/accommodative therapy or to placebo therapy. Improvements in (1) near point of convergence (NPC), (2) positive fusional vergence (PFV), and (3) self-reported symptoms (Convergence Insufficiency Symptom Survey [CISS] score) were compared after 16 weeks of treatment.

Results: Mean NPC improved 10.4 cm in the vergence/accommodative and 6.2 cm in the placebo therapy group (mean difference of -4.2 cm [95% confidence interval {CI}, -5.2 to -3.2 cm; P < .001]); mean PFV increased 23.2 and 8.8Δ in the vergence/accommodative and placebo therapy groups, respectively (mean difference of 14.4Δ [95% CI, 12.1 to 16.8Δ; P < .001]). The mean CISS score improved 11.8 and 10.4 points in the vergence/accommodative and placebo therapy groups, respectively (mean difference of 1.5 points [95% CI, -3.8 to +0.8 points; P = .21]).

Conclusions: Our results demonstrate that office-based vergence/accommodative therapy is effective for improving the NPC and PFV in children with symptomatic convergence insufficiency. However, given that both treatment groups had a similar reduction in self-reported symptoms, it may not be prudent to use the CISS alone as a measure of successful treatment.

Trial registration: ClinicalTrials.gov NCT00338611.

Conflict of interest statement

Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flowchart of CITT-ART randomized clinical trial study visits. CITT-ART = Convergence Insufficiency Treatment Trial–Attention & Reading Trial. aOne participant was determined to be ineligible after randomization; site’s IRB stated no data collected beyond baseline could be used.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6855327/bin/opx-96-825-g001.jpg

References

    1. Rouse MW, Borsting E, Hyman L, et al. Frequency of Convergence Insufficiency among Fifth and Sixth Graders. The Convergence Insufficiency and Reading Study (CIRS) Group. Optom Vis Sci 1999;76:643–9.
    1. Convergence Insufficiency Treatment Trial (CITT) Study Group. The Convergence Insufficiency Treatment Trial: Design, Methods, and Baseline Data. Ophthalmic Epidemiol 2008;15:24–36.
    1. Convergence Insufficiency Treatment Trial Study Group. Randomized Clinical Trial of Treatments for Symptomatic Convergence Insufficiency in Children. Arch Ophthalmol 2008;126:1336–49.
    1. Scheiman M, Mitchell GL, Cotter S, et al. A Randomized Trial of the Effectiveness of Treatments for Convergence Insufficiency in Children. Arch Ophthalmol 2005;123:14–24.
    1. Scheiman M, Cotter S, Rouse M, et al. Randomised Clinical Trial of the Effectiveness of Base-in Prism Reading Glasses versus Placebo Reading Glasses for Symptomatic Convergence Insufficiency in Children. Br J Ophthalmol 2005;89:1318–23.
    1. Scheiman M, Mitchell GL, Cotter S, et al. A Randomized Clinical Trial of Vision Therapy/Orthoptics versus Pencil Pushups for the Treatment of Convergence Insufficiency in Young Adults. Optom Vis Sci 2005;82:583–95.
    1. Letourneau JE, Ducic S. Prevalence of Convergence Insufficiency among Elementary School Children. Can J Optom 1988;50:194–7.
    1. Hussaindeen JR, Rakshit A, Singh NK, et al. Prevalence of Non-strabismic Anomalies of Binocular Vision in Tamil Nadu: Report 2 of Band Study. Clin Exp Optom 2017;100:642–8.
    1. Wajuihian SO, Hansraj R. Vergence Anomalies in a Sample of High School Students in South Africa. J Optom 2016;9:246–57.
    1. Davis AL, Harvey EM, Twelker JD, et al. Convergence Insufficiency, Accommodative Insufficiency, Visual Symptoms, and Astigmatism in Tohono O'odham Students. J Ophthalmol 2016;2016:6963976.
    1. Barnhardt C, Cotter SA, Mitchell GL, et al. Symptoms in Children with Convergence Insufficiency: Before and After Treatment. Optom Vis Sci 2012;89:1512–20.
    1. Cooper J, Jamal N. Convergence Insufficiency—A Major Review. Optometry 2012;83:137–58.
    1. Alvarez TL, Jaswal R, Gohel S, et al. Functional Activity within the Frontal Eye Fields, Posterior Parietal Cortex, and Cerebellar Vermis Significantly Correlates to Symmetrical Vergence Peak Velocity: An ROI-based, fMRI Study of Vergence Training. Front Integr Neurosci 2014;8:50.
    1. Alvarez TL, Vicci VR, Alkan Y, et al. Vision Therapy in Adults with Convergence Insufficiency: Clinical and Functional Magnetic Resonance Imaging Measures. Optom Vis Sci 2010;87:985–1002.
    1. Widmer DE, Oechslin TS, Limbachia C, et al. Post-therapy Functional Magnetic Resonance Imaging in Adults with Symptomatic Convergence Insufficiency. Optom Vis Sci 2018;95:505–14.
    1. CITT-ART Investigator Group. Effect of Vergence/Accommodative Therapy on Reading in Children with Convergence Insufficiency: A Randomized Clinical Trial. Optom Vis Sci 2019;96:836–49.
    1. CITT-ART Investigator Group. Convergence Insufficiency Treatment Trial–Attention and Reading Trial (CITT-ART): Design and Methods. Vis Dev Rehabil 2015;1:214–28.
    1. Sheard C. Zones of Ocular Comfort. Am J Optom 1930;7:9–25.
    1. Rouse M, Borsting E, Mitchell GL, et al. Validity of the Convergence Insufficiency Symptom Survey: A Confirmatory Study. Optom Vis Sci 2009;86:357–63.
    1. Borsting EJ, Rouse MW, Mitchell GL, et al. Validity and Reliability of the Revised Convergence Insufficiency Symptom Survey in Children Aged 9–18 Years. Optom Vis Sci 2003;80:832–8.
    1. Borsting E, Rouse MW, De Land PN. Prospective Comparison of Convergence Insufficiency and Normal Binocular Children on CIRS Symptom Surveys. Convergence Insufficiency and Reading Study (CIRS) Group. Optom Vis Sci 1999;76:221–8.
    1. Borsting E, Rouse MW, Deland PN, et al. Association of Symptoms and Convergence and Accommodative Insufficiency in School-age Children. Optometry 2003;74:25–34.
    1. Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)—A Metadata-driven Methodology and Workflow Process for Providing Translational Research Informatics Support. J Biomed Inform 2009;42:377–81.
    1. Scheiman M, Wick B. Clinical Management of Binocular Vision: Heterophoric, Accommodative and Eye Movement Disorders. Philadelphia: Lippincott, Williams and Wilkins; 2002.
    1. Kulp M, Mitchell GL, Borsting E, et al. Effectiveness of Placebo Therapy for Maintaining Masking in a Clinical Trial of Vergence/Accommodative Therapy. Invest Ophthalmol Vis Sci 2009;50:2560–6.
    1. Kulp M, Borsting E, Mitchell GL, et al. Feasibility of Using a Placebo Vision Therapy/Orthoptics Control in a Multicenter Clinical Trial. Optom Vis Sci 2008;85:255–61.
    1. Tignanelli CJ, Napolitano LM. The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care. JAMA Surg 2019;154:74–9.
    1. Shen C, Shamsudeen I, Farrokhyar F, et al. Fragility of Results in Ophthalmology Randomized Controlled Trials: A Systematic Review. Ophthalmology 2018;125:642–8.
    1. Shen Y, Cheng X, Zhang W. The Fragility of Randomized Controlled Trials in Intracranial Hemorrhage. Neurosurg Rev 2019;42:9–14.
    1. Feinstein AR. The Unit Fragility Index: An Additional Appraisal of “Statistical Significance” for a Contrast of Two Proportions. J Clin Epidemiol 1990;43:201–9.
    1. Walsh M, Srinathan SK, McAuley DF, et al. The Statistical Significance of Randomized Controlled Trial Results Is Frequently Fragile: A Case for a Fragility Index. J Clin Epidemiol 2014;67:622–8.
    1. Rouse MW, Borsting E, Deland PN. Reliability of Binocular Vision Measurements Used in the Classification of Convergence Insufficiency. Optom Vis Sci 2002;79:254–64.
    1. Clark TY, Clark RA. Convergence Insufficiency Symptom Survey Scores for Required Reading versus Leisure Reading in School-age Children. J AAPOS 2017;21:452–6.
    1. McGregor ML. Convergence Insufficiency and Vision Therapy. Pediatr Clin North Am 2014;61:621–30.
    1. Phillips PH. Pediatric Ophthalmology and Childhood Reading Difficulties: Convergence Insufficiency: Relationship to Reading and Academic Performance. J AAPOS 2017;21:444–6 e1.
    1. Giffard P, Daly L, Treleaven J. Influence of Neck Torsion on near Point Convergence in Subjects with Idiopathic Neck Pain. Musculoskelet Sci Pract 2017;32:51–6.
    1. Stiebel-Kalish H, Amitai A, Mimouni M, et al. The Discrepancy between Subjective and Objective Measures of Convergence Insufficiency in Whiplash-associated Disorder versus Control Participants. Ophthalmology 2018;125:924–8.
    1. Hrobjartsson A, Kaptchuk TJ, Miller FG. Placebo Effect Studies Are Susceptible to Response Bias and to Other Types of Biases. J Clin Epidemiol 2011;64:1223–9.
    1. Hróbjartsson A, Gøtzsche PC. Placebo Interventions for All Clinical Conditions. Cochrane Database Syst Rev 2010;CD003974.
    1. Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of Placebo Effect: Randomised Controlled Trial in Patients with Irritable Bowel Syndrome. BMJ 2008;336:999–1003.
    1. Miller FG, Colloca L, Kaptchuk TJ. The Placebo Effect: Illness and Interpersonal Healing. Perspect Biol Med 2009;52:518–39.
    1. Sinyor M, Levitt AJ, Cheung AH, et al. Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results from Pooled and Meta-analyses. J Clin Psychiatry 2010;71:270–9.
    1. Fregni F, Imamura M, Chien HF, et al. Challenges and Recommendations for Placebo Controls in Randomized Trials in Physical and Rehabilitation Medicine: A Report of the International Placebo Symposium Working Group. Am J Phys Med Rehabil 2010;89:160–72.
    1. Clark DL, Arnold LE, Crowl L, et al. Vestibular Stimulation for ADHD: Randomized Controlled Trial of Comprehensive Motion Apparatus. J Atten Disord 2008;11:599–611.
    1. Arnold LE, Lofthouse N, Hersch S, et al. EEG Neurofeedback for ADHD: Double-blind Sham-controlled Randomized Pilot Feasibility Trial. J Atten Disord 2013;17:410–9.
    1. Papakostas GI, Fava M. Does the Probability of Receiving Placebo Influence Clinical Trial Outcome? A Meta-regression of Double-blind, Randomized Clinical Trials in MDD. Eur Neuropsychopharmacol 2009;19:34–40.
    1. Hofstetter HW. Useful Age-Amplitude Formula. Optometric World 1950;38:42–5.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner